President-elect Donald Trump arrives to speak at a meeting of the House GOP conference, followed by Rep. Elise Stefanik, R-N.Y., last week in Washington. Alex Brandon/Associated Press NEW YORK — A number of President-elect Donald Trump ‘s most prominent Cabinet picks and appointees have been targeted by bomb threats and “swatting attacks,” Trump’s transition team said Wednesday. The FBI said it was investigating. “Last night and this morning, several of President Trump’s Cabinet nominees and Administration appointees were targeted in violent, unAmerican threats to their lives and those who live with them,” Trump transition spokesperson Karoline Leavitt said in a statement. She said the attacks ranged from bomb threats to swatting, in which attackers initiate an emergency law enforcement response against a target victim under false pretenses. The tactic has become a popular one in recent years. Leavitt said law enforcement and other authorities acted quickly to ensure the safety of those who were targeted and Trump and his transition team are grateful. Among those targeted were New York Rep. Elise Stefanik, Trump’s pick to serve as the next ambassador to the United Nations; Matt Gaetz, Trump’s initial pick to serve as attorney general; and former New York congressman Lee Zeldin, who has been tapped to lead the Environmental Protection Agency. Law enforcement officials are also looking into whether Susie Wiles, Trump’s incoming chief of staff, and Pam Bondi, the former Florida attorney general whom Trump has chosen as Gaetz’s replacement, and other incoming administration officials were also victims – as well as how each was targeted, according to a law enforcement official who spoke on condition of anonymity as the investigation continues. Wiles and Bondi did not immediately respond to requests for comment. The FBI said in a statement that it was “aware of numerous bomb threats and swatting incidents targeting incoming administration nominees and appointees” and was investigating with its law enforcement partners. The FBI added: “We take all potential threats seriously, and as always, encourage members of the public to immediately report anything they consider suspicious to law enforcement.” A pipe bomb threat targeting me and my family at our home today was sent in with a pro-Palestinian themed message. My family and I were not home at the time and are safe. We are working with law enforcement to learn more as this situation develops. We are thankful for the swift... — Lee Zeldin (@LeeMZeldin) November 27, 2024 White House spokesperson Saloni Sharma said President Biden had been briefed and the White House is in touch with federal law enforcement and Trump’s transition team. Biden “continues to monitor the situation closely,” Sharma said, adding the president and his administration “condemn threats of political violence.” Stefanik’s office said that, on Wednesday morning, she, her husband, and their 3-year-old son were driving home from Washington for Thanksgiving when they were informed of a bomb threat to their residence in Saratoga County. Her office said “New York State, County law enforcement, and U.S. Capitol Police responded immediately with the highest levels of professionalism.” The New York State Police said a team was dispatched to sweep Stefanik’s home on Wednesday morning in response to the bomb threat but did not locate any explosive devices. The agency directed further questions to the FBI. Zeldin said in a social media post that he and his family had been threatened. “A pipe bomb threat targeting me and my family at our home today was sent in with a pro-Palestinian themed message,” he wrote on X . “My family and I were not home at the time and are safe. We are working with law enforcement to learn more as this situation develops.” Police in Suffolk County, Long Island, said emergency officers responded to a bomb threat Wednesday morning at an address listed in public records as Zeldin’s home and were checking the property. In Florida, the Okaloosa County sheriff’s office said on Facebook that it “received notification of a bomb threat referencing former Congressman Matt Gaetz’s supposed mailbox at a home in the Niceville area” around 9 a.m. Wednesday. While a family member resides at the address, the office said, Gaetz “is NOT a resident.” No threatening devices were found. Gaetz was Trump’s initial pick to serve as attorney general, but he withdrew from consideration after allegations that he paid women for sex and slept with underage women. Gaetz has vehemently denied any wrongdoing and said last year that a Justice Department investigation into sex trafficking allegations involving underage girls had ended with no federal charges against him. The threats follow a political campaign marked by disturbing and unprecedented violence. In July, a gunman opened fire at a Trump rally in Butler, Pennsylvania, grazing the then-candidate in the ear with a bullet and killing one of his supporters. The Secret Service later thwarted a subsequent assassination attempt at Trump’s West Palm Beach, Florida, golf course when an agent spotted the barrel of a gun poking through a perimeter fence while Trump was golfing. Trump was also the subject of an Iranian murder-for-hire plot, with a man saying he had been tasked with planning the assassination of the Republican president-elect. Also this week, authorities arrested a man they say posted videos on social media threatening to kill Trump, according to court documents. In one video posted on Nov. 13, Manuel Tamayo-Torres threatened to shoot the former president while holding what appeared to be an AR-15 style rifle, authorities said Among the other videos he posted was one from an arena in Glendale, Arizona on Aug. 23, the same day Trump held a campaign rally there, according to court papers. An attorney for Tamayo-Torres did not immediately respond to a request for comment Wednesday. Public figures across the political spectrum have been targeted in recent years by hoax bomb threats and false reports of shootings at their homes. About a year ago the FBI responded to an uptick in such incidents at the homes of public officials, state capitols and courthouses across the country around the holidays. Many were locked down and evacuated in early January after receiving bomb threats. No explosives were found and no one was hurt. Some of those targeted last year were Georgia Lt. Gov. Burt Jones, Boston Mayor Michelle Wu and Ohio Attorney General Dave Yost. This year, there was not just one but TWO assassination attempts on President Trump. Now some of his Cabinet nominees and their families are facing bomb threats. This is dangerous and unhinged. It is not who we are in America. Joe Biden and all Democrat leaders have an... https://t.co/0xZztX4DQo — Speaker Mike Johnson (@SpeakerJohnson) November 27, 2024 In Wu’s case, a male caller told police he had shot his own wife and tied another man up. When police and EMT responders arrived at the address given by the caller, they quickly realized it was the Boston mayor’s home. Wu, a Democrat, has also been targeted by many swatting calls since she took office in 2021. The judges overseeing the civil fraud case against Trump in New York and the criminal election interference case against him in Washington were both targeted earlier this year. Justice Department special counsel Jack Smith, who recently abandoned the two criminal cases he brought against Trump, was also the subject of a fake emergency call on Christmas Day last year. Earlier this year, schools, government buildings and the homes of city officials in Springfield, Ohio, received a string of hoax bomb threats after Trump falsely accused members of Springfield’s Haitian community of abducting and eating cats and dogs. And in 2022, a slew of historically Black colleges and universities nationwide were targeted with dozens of bomb threats, with the vast majority arriving during the celebration of Black History Month. The U.S. Capitol Police said in a statement Wednesday that anytime a member of Congress is the victim of a swatting’ incident, “we work closely with our local and federal law enforcement partners.” The force declined to provide further details, in part to “minimize the risk of copy-cats.” Republican House Speaker Mike Johnson called the threats “dangerous and unhinged.” “This year, there was not just one but TWO assassination attempts on President Trump,” he wrote on X . “Now some of his Cabinet nominees and their families are facing bomb threats.” He added: “It is not who we are in America.” Associated Press writers Colleen Long and Eric Tucker in Washington, Scott Bauer in Madison, Wisconsin, and Anthony Izaguirre in Albany, New York, contributed to this report. Comments are not available on this story. Send questions/comments to the editors. « Previous( ) stock had its upgraded from 82 to 91 Monday. This exclusive rating from Investor's Business Daily tracks market leadership with a 1 (worst) to 99 (best) score. The score shows how a stock's price behavior over the trailing 52 weeks stacks up against all the other stocks in our database. Over 100 years of market history shows that the best stocks tend to have an RS Rating north of 80 as they launch their biggest climbs. Is Alpha & Omega Semiconductor Stock A Buy? Alpha & Omega Semiconductor stock is building a consolidation with a 47.45 . See if the stock can clear the breakout price in volume at least 40% above average. Earnings grew -36% last quarter, up from -53% in the prior report. Revenue also increased, from 0% to 1%. Alpha & Omega Semiconductor stock earns the No. 21 rank among its peers in the Electronics-Semiconductor Fabless industry group. ( ), ( ) and ( ) are among the top 5 highly rated stocks within the group. For more industry news, check out " ."
THOUSAND OAKS, Calif. , Dec. 10, 2024 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced that its Board of Directors declared a $2.38 per share dividend for the first quarter of 2025. The dividend will be paid on March 7, 2025 , to all stockholders of record as of the close of business on February 14, 2025 . About Amgen Amgen discovers, develops, manufactures and delivers innovative medicines to help millions of patients in their fight against some of the world's toughest diseases. More than 40 years ago, Amgen helped to establish the biotechnology industry and remains on the cutting-edge of innovation, using technology and human genetic data to push beyond what's known today. Amgen is advancing a broad and deep pipeline that builds on its existing portfolio of medicines to treat cancer, heart disease, osteoporosis, inflammatory diseases and rare diseases. In 2024, Amgen was named one of the "World's Most Innovative Companies" by Fast Company and one of "America's Best Large Employers" by Forbes, among other external recognitions . Amgen is one of the 30 companies that comprise the Dow Jones Industrial Average ® , and it is also part of the Nasdaq-100 Index ® , which includes the largest and most innovative non-financial companies listed on the Nasdaq Stock Market based on market capitalization. For more information, visit Amgen.com and follow Amgen on X , LinkedIn , Instagram , TikTok , YouTube and Threads . Forward-Looking Statements This news release contains forward-looking statements that are based on the current expectations and beliefs of Amgen. All statements, other than statements of historical fact, are statements that could be deemed forward-looking statements, including any statements on the outcome, benefits and synergies of collaborations, or potential collaborations, with any other company (including BeiGene, Ltd. or Kyowa Kirin Co., Ltd.), the performance of Otezla® (apremilast) (including anticipated Otezla sales growth and the timing of non-GAAP EPS accretion), our acquisitions of Teneobio, Inc., ChemoCentryx, Inc., or Horizon Therapeutics plc (including the prospective performance and outlook of Horizon's business, performance and opportunities, any potential strategic benefits, synergies or opportunities expected as a result of such acquisition, and any projected impacts from the Horizon acquisition on our acquisition-related expenses going forward), as well as estimates of revenues, operating margins, capital expenditures, cash, other financial metrics, expected legal, arbitration, political, regulatory or clinical results or practices, customer and prescriber patterns or practices, reimbursement activities and outcomes, effects of pandemics or other widespread health problems on our business, outcomes, progress, and other such estimates and results. Forward-looking statements involve significant risks and uncertainties, including those discussed below and more fully described in the Securities and Exchange Commission reports filed by Amgen, including our most recent annual report on Form 10-K and any subsequent periodic reports on Form 10-Q and current reports on Form 8-K. Unless otherwise noted, Amgen is providing this information as of the date of this news release and does not undertake any obligation to update any forward-looking statements contained in this document as a result of new information, future events or otherwise. No forward-looking statement can be guaranteed and actual results may differ materially from those we project. Our results may be affected by our ability to successfully market both new and existing products domestically and internationally, clinical and regulatory developments involving current and future products, sales growth of recently launched products, competition from other products including biosimilars, difficulties or delays in manufacturing our products and global economic conditions. In addition, sales of our products are affected by pricing pressure, political and public scrutiny and reimbursement policies imposed by third-party payers, including governments, private insurance plans and managed care providers and may be affected by regulatory, clinical and guideline developments and domestic and international trends toward managed care and healthcare cost containment. Furthermore, our research, testing, pricing, marketing and other operations are subject to extensive regulation by domestic and foreign government regulatory authorities. We or others could identify safety, side effects or manufacturing problems with our products, including our devices, after they are on the market. Our business may be impacted by government investigations, litigation and product liability claims. In addition, our business may be impacted by the adoption of new tax legislation or exposure to additional tax liabilities. If we fail to meet the compliance obligations in the corporate integrity agreement between us and the U.S. government, we could become subject to significant sanctions. Further, while we routinely obtain patents for our products and technology, the protection offered by our patents and patent applications may be challenged, invalidated or circumvented by our competitors, or we may fail to prevail in present and future intellectual property litigation. We perform a substantial amount of our commercial manufacturing activities at a few key facilities, including in Puerto Rico , and also depend on third parties for a portion of our manufacturing activities, and limits on supply may constrain sales of certain of our current products and product candidate development. An outbreak of disease or similar public health threat, such as COVID-19, and the public and governmental effort to mitigate against the spread of such disease, could have a significant adverse effect on the supply of materials for our manufacturing activities, the distribution of our products, the commercialization of our product candidates, and our clinical trial operations, and any such events may have a material adverse effect on our product development, product sales, business and results of operations. We rely on collaborations with third parties for the development of some of our product candidates and for the commercialization and sales of some of our commercial products. In addition, we compete with other companies with respect to many of our marketed products as well as for the discovery and development of new products. Discovery or identification of new product candidates or development of new indications for existing products cannot be guaranteed and movement from concept to product is uncertain; consequently, there can be no guarantee that any particular product candidate or development of a new indication for an existing product will be successful and become a commercial product. Further, some raw materials, medical devices and component parts for our products are supplied by sole third-party suppliers. Certain of our distributors, customers and payers have substantial purchasing leverage in their dealings with us. The discovery of significant problems with a product similar to one of our products that implicate an entire class of products could have a material adverse effect on sales of the affected products and on our business and results of operations. Our efforts to collaborate with or acquire other companies, products or technology, and to integrate the operations of companies or to support the products or technology we have acquired, may not be successful. There can be no guarantee that we will be able to realize any of the strategic benefits, synergies or opportunities arising from the Horizon acquisition, and such benefits, synergies or opportunities may take longer to realize than expected. We may not be able to successfully integrate Horizon, and such integration may take longer, be more difficult or cost more than expected. A breakdown, cyberattack or information security breach of our information technology systems could compromise the confidentiality, integrity and availability of our systems and our data. Our stock price is volatile and may be affected by a number of events. Our business and operations may be negatively affected by the failure, or perceived failure, of achieving our environmental, social and governance objectives. The effects of global climate change and related natural disasters could negatively affect our business and operations. Global economic conditions may magnify certain risks that affect our business. Our business performance could affect or limit the ability of our Board of Directors to declare a dividend or our ability to pay a dividend or repurchase our common stock. We may not be able to access the capital and credit markets on terms that are favorable to us, or at all. CONTACT: Amgen, Thousand Oaks Elissa Snook , 609-251-1407 (media) Justin Claeys , 805-313-9775 (investors) View original content to download multimedia: https://www.prnewswire.com/news-releases/amgen-announces-2025-first-quarter-dividend-302328180.html SOURCE AmgenDec 2 - Art Cashin, UBS' director of floor operations at the New York Stock Exchange who spent more than 60 years on Wall Street, has died aged 83. "It is with a heavy heart that I inform you of the passing of Arthur Cashin, Jr., a true giant in our industry, highly regarded market pundit," Bill Carroll, head of sales and development at UBS Wealth Management USA, said in a memo to employees which was seen by Reuters on Monday. Cashin, dubbed 'Wall Street's version of Walter Cronkite' by The Washington Post, was a regular on CNBC, delivering stock market commentary and analysis to the business news channel's viewers for more than 25 years. He began his business career at Thomson McKinnon in 1959. In 1964, at age 23, he became a member of the NYSE and a partner of P.R. Herzig & Co. In 1980, Cashin joined investment bank PaineWebber and managed their floor operation. PaineWebber was acquired by UBS in 2000. At that time, the NYSE floor was the hub for the vast majority of all trading activity in the United States. Cashin was one of three senior executive floor governors and also served as a member of the Bond Club of New York. He was also part of the high-IQ society Mensa. In addition to his role at UBS, he is renowned for his daily newsletter, Cashin's Comments, which has been published for over 25 years and reaches more than 100,000 readers daily. He has also been a regular on CNBC's Art Cashin on the Markets, a segment airing several times a week, for more than two decades. "It's fair to say that over this time, Art Cashin became a household name for investors across the country, who benefited from his savvy insight on the markets, good humor and wit, while being one of UBS's strongest brand ambassadors," the memo said. Cashin was born in Jersey City, New Jersey, in 1941, according to CNBC, which first reported on his death. CNBC did not immediately respond to a Reuters request for comment. Cashin's family could not be reached for comment. This article was generated from an automated news agency feed without modifications to text.West Virginia knocks off No. 3 Gonzaga 86-78 in overtime in the Battle 4 Atlantis
Apple Pulls iPhone 14 and SE from Europe as USB-C Mandate Changes the Game
CLEVELAND — The NBA's leader in assists handed Cleveland a rare loss. Trae Young got a career-high 22 assists — the most in the league this season — as the Atlanta Hawks pulled off a 135-124 upset Thursday night of the Cavaliers, who dropped to 17-2 and lost for the first time in 11 home games this season. One of the game's deepest shooters, Young also made a 39-foot 3-pointer in the final two minutes as the Hawks snapped a three-game losing streak and got their second major road win after knocking off the champion Celtics in Boston on Nov. 12. Young's assist total was one better than the 21 recorded by New Orleans guard Elfrid Payton earlier this week against Indiana. It was also just one shy of the Hawks' team record held by Mookie Blaylock, who got 23 assists on March 6, 1993 against Utah. “He threw himself into the game,” Hawks coach Quin Snyder said of Young, who came into the game averaging 11.9 assists. "The biggest thing is he just moved the ball, and he forced guys to run. He gave guys opportunities in the open court and he trusted his teammates.” Young picked up eight assists in the fourth quarter as the Hawks outplayed the Cavs down the stretch. Young fed teammate De'Andre Hunter for two baskets, Dyson Daniels for another and made two free throws to put the Hawks up 126-118. Moments later, Young lost the handle and Ty Jerome's 3-pointer pulled the Cavs within 126-122. Atlanta Hawks guard Trae Young (11) is congratulated by forward Jalen Johnson after the Hawks defeated the Cleveland Cavaliers 135-124 in an NBA basketball game, Wednesday, Nov. 27, 2024, in Cleveland. Credit: AP/David Dermer Young nearly gave it away again, but after corralling the loose ball, he drilled his 3-pointer just inside the half-court logo to put Atlanta ahead by seven. “I couldn’t let my team down twice in a row, so I had to make the play,” said Young. "I think when I got the ball back I still had 10 seconds left, so I had a little time to make a play and that’s what happened.” The bucket silenced Cleveland's rocking crowd. And if they needed any reminder, Young reminded them to be quiet by pressing his index finger to his mouth. The Hawks have grown accustomed to Young coming through in the clutch. The three-time All-Star has a knack for big moments, and while his ability to launch 3-pointers is often the focus, his passing game is often overlooked. “For the smallest guy on the floor, he sees it really well,” said Hunter, who finished with 26 points. “He makes on-time passes, usually where guys can shoot it and we made a lot of shots tonight.” Snyder said Young's leadership late in the game was as vital as anything. “I really liked the way we and he reacted to being down,” Snyder said. "Just keeping his poise, that’s always been a point of emphasis with Trae.” Following the game, Young came into the media room cradling a basketball as if he was protecting it on a drive. As he wrapped up his availability, Young was asked if he knew he had just set a career-best in assists. “I didn't until just now. Thank you," he said.Gov. Kemp picked to lead Republican Governors Association